Paul V Shellabarger, PAC in Indianola, NE - Physician Assistant

Paul V Shellabarger, PAC is a Physician Assistant based in Indianola, Nebraska. Paul V Shellabarger is licensed to practice in Nebraska (license number NE389000) and his current practice location is 119 South 4th, Indianola, Nebraska. He can be reached at his office (for appointments etc.) via phone at (308) 364-9290.

NPI number for Paul V Shellabarger is 1265529796 and his current mailing address is Po Box 488, Cambridge, Nebraska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1265529796.

Contact Information

	Paul V Shellabarger, PAC
	119 South 4th, Indianola, NE 69034
	(308) 364-9290
	(308) 697-3278

Provider's Profile

Full Name	Paul V Shellabarger
Gender	Male
Speciality	Physician Assistant
Location	119 South 4th, Indianola, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1265529796
Provider Enumeration Date: 10/06/2006
Last Update Date: 01/05/2010

Medical Identifiers

Medical identifiers for Paul V Shellabarger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265529796	NPI	-	NPPES
389	Medicaid	NE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363A00000X	Physician Assistant	NE389000 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul V Shellabarger is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paul V Shellabarger, PAC Po Box 488, Cambridge, NE 69022-0488 Ph: (308) 697-3317	Paul V Shellabarger, PAC 119 South 4th, Indianola, NE 69034 Ph: (308) 364-9290

News Archive

Bird flu put 51 in quarantine in Manipur

India's health ministry says 51 people in Manipur have been quarantined following an outbreak of the H5N1 strain of influenza in chickens last month in the northeastern Indian state.

New study paves way for patient-specific regenerative therapies for inflammatory bowel diseases

A source of gut stem cells that can repair a type of inflammatory bowel disease when transplanted into mice has been identified by researchers at the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute at the University of Cambridge and at BRIC, the University of Copenhagen, Denmark.

Researchers study new strategies to treat patients with influenza

Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways that the flu uses for replication, University of Georgia researchers are finding new strategies for therapies and vaccines, according to a study published in the January issue of the Journal of the Federation of American Societies for Experimental Biology.

Patient enrollment completed in Phase 2b clinical trial for Pyridorin

NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.

Paul V Shellabarger, PAC - Physician Assistant in Indianola, NE